Blood metal concentrations and cardiac structure and function in total joint arthroplasty patients

Peter C Brennan1, Stephanie M Peterson2, Thomas J O'Byrne2

  • 1Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN 55905, United States.

PubMed

Insights

Concerns about metal toxicity in total joint arthroplasty (TJA) patients are rising. This study found elevated cobalt and titanium levels linked to cardiac structural changes, highlighting the need for further research into these systemic effects.

Area of Science:

  • Biomaterials science
  • Cardiology
  • Orthopedic surgery

Background:

  • Systemic distribution of metals from total joint arthroplasty (TJA) raises concerns about potential long-term cardiotoxicity.
  • Understanding the cardiac implications of metal ion release is crucial for patient safety.

Purpose of the Study:

  • To investigate the association between commonly used implant metals (chromium, cobalt, titanium) and echocardiographic measures in TJA patients.
  • To identify potential cardiac alterations related to elevated metal concentrations.

Main Methods:

  • 110 TJA patients with elevated chromium, cobalt, or titanium levels were assessed.
  • Comprehensive echocardiography (2D, 3D, Doppler, speckle-strain) was performed.
  • Blood samples measured metal concentrations; regression models analyzed associations with cardiac outcomes.

Main Results:

  • Higher cobalt concentrations correlated with increased left ventricular end-diastolic volume and atrial/right ventricular dilation, especially in men.
  • Higher titanium concentrations were associated with reduced left ventricle global longitudinal strain and cardiac index.
  • No significant changes in overall cardiac function were observed.

Conclusions:

  • Elevated cobalt and titanium levels may be linked to structural and functional cardiac changes in TJA patients.
  • Further longitudinal studies are necessary to elucidate the long-term systemic effects of implant metals.
Abstract